Cargando…
Hypovitaminosis D and the endocrine phenotype of COVID-19
BACKGROUND: Vitamin D and its deficiency have recently been suspected to be involved in increased susceptibility and negative outcomes of COVID-19. This assumption was based on the well known immunomodulatory actions of vitamin D and on the consistent finding of low levels of 25 hydroxyvitamin D (25...
Autor principal: | Giustina, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972333/ https://www.ncbi.nlm.nih.gov/pubmed/33738708 http://dx.doi.org/10.1007/s12020-021-02671-8 |
Ejemplares similares
-
Hypovitaminosis D: Is It Time to Consider the Use of Calcifediol?
por: Cesareo, Roberto, et al.
Publicado: (2019) -
Associations between hypovitaminosis D and COVID-19: a narrative review
por: Isaia, Giancarlo, et al.
Publicado: (2020) -
Hypovitaminosis D and COVID-19: Matter of Concern in India?
por: Suresh, Padmanaban S.
Publicado: (2020) -
Hypovitaminosis D and Metabolic Syndrome in Postmenopausal Women
por: Abuhijleh, Haya, et al.
Publicado: (2022) -
Prevalence of hypovitaminosis D in India & way forward
por: Kamboj, Preeti, et al.
Publicado: (2018)